John Michael Beals
9Patents
4h-index
23Co-inventors
53Inventor score
Filing activity: Dec 1, 2004 → Jan 18, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7491697B2 | Muteins of fibroblast growth factor 21 | Human Necessities | 94 | Expired |
| US9855318B2 | Fusion proteins | Chemistry; Metallurgy | 19 | Active |
| US10709766B2 | Fusion proteins | Chemistry; Metallurgy | 18 | Active |
| US10035839B2 | Blood glucose lowering compound | Chemistry; Metallurgy | 4 | Active |
| US9050371B2 | PEGylated insulin lispro compounds | Chemistry; Metallurgy | 1 | Active |
| US9259479B2 | Treatment for comorbid diabetes with chronic kidney disease | Human Necessities | 0 | Active |
| US11253574B2 | Fusion proteins and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11510967B2 | Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol | Human Necessities | 0 | Active |
| US12059452B2 | Fusion proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.